Market revenue in 2023 | USD 85.4 million |
Market revenue in 2030 | USD 128.6 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Topical |
Fastest growing segment | Topical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Topical |
Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.61% in 2023. Horizon Databook has segmented the Brazil onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
Onychomycosis is a very common condition in Brazil with the availability of medications and treatments that have very low cure rates. Several players, such as companies & research institutes, are focusing on the development of novel and effective therapeutics, which is driving the overall market.
Furthermore, researchers from Brazil stated that the prevalence of onychomycosis in Maringá, Brazil, had increased in recent years, aligning with global patterns and advancements in healthcare services.
The study analyzed toenail and fingernail samples from three patients with suspected onychomycosis, exploring Propolis Extract (PE) as a potential antifungal treatment.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into Brazil onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account